期刊文献+

Elf-1与survivin在非小细胞肺癌中的表达及临床意义 被引量:3

Expression of Elf-1 and survivin and Their Clinical Implication in Non-small Cell Lung Cancer
暂未订购
导出
摘要 目的探讨转录因子Elf-1与凋亡抑制因子survivin在非小细胞肺癌中的表达及它们与临床病理因素之间的关系。方法收集72例非小细胞肺癌组织,应用组织芯片仪制备组织芯片,采用免疫组化PowerVisionTM-9000(PV-9000)法检测Elf-1、survivin的表达。结果在72例非小细胞肺癌组织中,Elf-1阳性染色定位于肺癌细胞核及胞质,阳性表达53例(73.61%),其表达强度与非小细胞肺癌的分化程度有关(χ2=14.849,P=0.021)。不同临床分期的非小细胞肺癌组织中Elf-1表达强度差异有统计学意义(χ2=24.127,P=0.000),Elf-1表达强度在淋巴结有转移组显著高于淋巴结无转移组(χ2=18.342,P=0.000);survivin阳性染色定位于肺癌细胞核及胞质,阳性表达44例(61.11%),其表达强度与非小细胞肺癌的分化程度有关(χ2=16.251,P=0.012),不同临床分期的非小细胞肺癌组织中sur-vivin表达强度差异有统计学意义(χ2=20.570,P=0.000),survivin表达强度在淋巴结有转移组显著高于淋巴结无转移组(χ2=8.723,P=0.033);非小细胞肺癌组织中Elf-1与survivin的表达强度呈极显著性正相关(τ=0.255,P<0.05)。结论Elf-1的表达强度与survivin的表达程度密切相关,均与肺癌细胞分化程度、临床分期及淋巴结转移有关,提示两者均可成为评估非小细胞肺癌生物学行为的重要指标。 Objective To study the expression of Elfq and relationship with survivin and biological behaveior in non-small cell lung cancer (NSCLC). Methods Tissue microarray from 72 cases of NSCLC was developed. The expression of Elf-1 and survivin were detected hy immunoistoehemistry staining with PV-9000 method. Results Elf-1 was mostly located in nucleus and in cytoplasm. The positive expression of Elf-1 was observed in 53 cases(73.61%), and its intensity of expression was related to the differentiation stages of the cancer (Х^2 = 14. 849, P = 0. 021), and significant differences were observed between different clinical stages (Х^2 = 24. 127,P = 0. 000). The intensity of Elf-1 expression was significantly higher in the group with lymph node metastasis than that without (Х^2 = 18. 342, P = 0. 000) ; Positive expression of survivin was also observed in 44 cases(61.11%), its intensity of expression was related to the differentiation stages of the cancer (Х^2 = 16. 251, P = 0. 012), and significant differences were noticed between different clinical stages (Х^2 = 20. 570, P = 0. 000). The intensity of survivin expression was significantly higher in the group with lymph node metastasis than that without (Х^2 = 8. 723, P = 0. 033) ; Positive correlation was found between the expression intensity of Elf-1 and survivin(r = 0. 255, P〈 0. 05). Conclusion The expression intensity of Elf-1 is closely correlated with survivin. The expression of Elf-1 and wurvivin is related to differentiation degree, clinical stage and lymph node metastasis of non- small-cell lung cancer. Elf-1 and survivin might serve as important parameters in evaluating biological behaviors of non small cell lung cancer.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2009年第4期306-309,共4页 Cancer Research on Prevention and Treatment
关键词 非小细胞肺癌 膜附着型本体A2 蛋白质阵列分析 免疫组织化学 Non-small cell lung carcinoma Ephrin-A2 Protein array analysis Immunohistochemistry
  • 相关文献

参考文献10

  • 1Singh S,Barrett J,Sakata K, et al. ETS proteins and MMPs: partners in invasion and metastasis[J]. Curr Drug Targets, 2002,3(5) :359-367.
  • 2Lu CD,Altieri DC, Tanigawa N, et al. Expression of a novel anti-apoptosis gene, Survivin, correlated with tumor cell apoptosis and P53 accumulation in gastric carcinomas [J]. Cancer Res, 1998,58(22) : 1802-1086.
  • 3Richter J,Wagner U, Kononen J, et al. High throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer[J]. Am J Pathol, 2000, 157 (3):787-794.
  • 4江晨,崔琳,纪萍,于建宪.胃癌组织中HGF/c-Met的组织芯片检测及其与肿瘤血管生成关系[J].齐鲁医学杂志,2005,20(3):211-213. 被引量:13
  • 5张健,高福禄,刘芝华.Ets转录因子家族在发育和肿瘤发生中作用的研究进展[J].世界华人消化杂志,2003,11(10):1624-1627. 被引量:10
  • 6Xu LH,Courtney B, Wei HN, et al. Critical role for the ETs transcription factor ELF-1 in the development of tumor anglogenesis [J]. Blood,2006,107(8) :3153 3160.
  • 7周红梅,李卫花,翟玉珍.Elf-1在肿瘤浸润转移中的转录调控研究进展[J].医学综述,2007,13(13):996-997. 被引量:6
  • 8Takai N,Miyazaki T, Nishida M, et al. Clinical relevance of Elf-1 overexpression in endometrial carcinoma[J]. Gynecologic Oncology, 2003,89 (3) : 408-413.
  • 9董德琼,薛东鹰,杨渝浩.Survivin蛋白在肺腺癌中的表达及临床意义[J].国际呼吸杂志,2006,26(2):92-94. 被引量:11
  • 10Tamm I,wang Y, Sausvile E, et al. IAP family protein surviving inhibits caspase activity and apoptosis induced by Fas (CD95), bax, caspase, and anticancer drugs [J]. Cancer Res, 1998,58(23) :5315-5320.

二级参考文献62

  • 1Seki Y, Suico MA, Uto A, Hisatsune A, Shuto T, Isohama Y,Kai H. The ETS transcription factor MEF is a candidate tumor suppressor gene on the X chromosome. Cancer Res 2002;62:6579-6586.
  • 2Singh S, Barrett J, Sakata K, Tozer RG, Singh G. ETS proteins and MMPs: partners in invasion and metastasis. Curr Drug Targets 2002;3:359-367.
  • 3Naito S, Shimizu K, Nakashima M, Nakayama T, Ito T, Ito M,Yamashita S, Sekine I. Overexpression of Ets-1 transcription factor in angiosarcoma of the skin. Pathol Res Pract 2000;196:103-109.
  • 4Ozaki I, Mizuta T, Zhao G, Yotsumoto H, Hara T, Kajihara S,Hisatomi A, Sakai T, Yamamoto K. Involvement of the Ets-1 gene in overexpression of matrilysin in human hepatocellular carcinoma. Cancer Res 2000;60:6519-6525.
  • 5Benbow U, Tower GB, Wyatt CA, Buttice G, Brinckerhoff CE.High levels of MMP-1 expression in the absence of the 2G single nucleotide polymorphism is mediated by p38 and ERK1/2 mitogen-activated protein kinases in VMM5 melanoma cells. J Cell Biochem 2002;86:307-319.
  • 6Hanzawa M, Shindoh M, Higashino F, Yasuda M, Inoue N,Hida K, Ono M, Kohgo T, Nakamura M, Notani K, FukudaH, Totsuka Y, Yoshida K, Fujinaga K. Hepatocyte growth factor upregulates EIAF that induces oral squamous cell carcinoma cell invasion by activating matrix metalloproteinase genes. Carcinogenesis 2000:21:1079-1085.
  • 7Behrens P, Rothe M, Wellmann A, Krischler J, Wernert N. The Ets-1 transcription factor is up-regulated together with MMP 1 and MMP 9 in the stroma of pre-invasive breast cancer. J Pathol 2001;194:43-50.
  • 8Sato T, Miwa A. Ets-1 and integrin beta3 for lung metastasis from colorectal cancer. APMIS 2002;110:347-353.
  • 9Nakayama T, Ito M, Ohtsuru A, Naito S, Sekine I. Expression of the ets-1 proto-oncogene in human colorectal carcinoma.Mod Pathol 2001;14:415-422.
  • 10Kanda K, Nakayama T, Onizuka S, Tomioka T, Kanematsu T. Expression of the Ets-1 proto-oncogene is linked to cell differentiation of human hepatocellular carcinoma.Hepatogastroenterology 2002;49:747-751.

共引文献34

同被引文献12

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部